Cleared Special

K172743 - Natus VikingQuest

K172743 is an FDA 510(k) clearance for Natus VikingQuest, manufactured by Natus Neurology Incorporated. The device is a Class 2 Neurology device with product code IKN cleared through the Special 510(k) pathway after a 98-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2017
Decision
98d
Days
Class 2
Risk

K172743 is an FDA 510(k) clearance for the Natus VikingQuest. Classified as Electromyograph, Diagnostic (product code IKN), Class II - Special Controls.

Submitted by Natus Neurology Incorporated (Middleton, US). The FDA issued a Cleared decision on December 19, 2017 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 890.1375 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Natus Neurology Incorporated devices

FDA 510(k) Submission Details - K172743

510(k) Number K172743 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 2017
Decision Date December 19, 2017
Days to Decision 98 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 149d · This submission: 98d
Pathway characteristics
Modification to existing cleared device.

IKN Device Classification - Class 2, Special Controls

Product Code IKN Electromyograph, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.1375
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - IKN Electromyograph, Diagnostic

All 48
Devices cleared under the same product code (IKN) and FDA review panel - the closest regulatory comparables to K172743.
ViMove2
K163150 · Dorsavi, Ltd. · Jul 2017
Cadwell Sierra Summit, Cadwell Sierra Ascent
K162383 · Cadwell Industries, Inc. · Mar 2017
ViMove
K142494 · Dorsavi, Ltd. · May 2015
VIMOVE
K131094 · Dorsa VI Pty., Ltd. · Jul 2014
PHYSICAL MONITORING REGISTRATION UNIT-S (PMRU-S)
K123902 · Oktx, LLC · Sep 2013
MYOVISION 3.0 WIREFREE SYSTEM
K123399 · Precision Biometrics, Inc. · Aug 2013